Carl Olsson, MD, FACS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    miR Scientific
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Dendreon Pharmaceuticals, LLC
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Myriad Genetics Inc
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Urotronic Robust III study
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    National Cancer Institute
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Astellas
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Spouse or Partner
    Type of financial relationship:
    Stock
    Ineligible company:
    exilixis
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    American Urological Assn
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other Business Ownership
    Ineligible company:
    Dianon
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    miR Scientific
    Date added:
    Date updated:
    04/13/2022

Pages

Return to Oral Board Review Course (2020)